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ABSTRACT: Bacterial transcription factors (TFs) are key devices for the engineering of complex circuits in many
biotechnological applications, yet there are few well-characterized inducer-responsive TFs that could be used in the context of
an animal or human host. We have deciphered the inducer recognition mechanism of two AraC/XylS regulators from
Pseudomonas putida (BenR and XylS) for creating a novel expression system responsive to acetyl salicylate (i.e., aspirin). Using
protein homology modeling and molecular docking with the cognate inducer benzoate and a suite of chemical analogues, we
identified the conserved binding pocket of BenR and XylS. By means of site-directed mutagenesis, we identified a single amino
acid position required for efficient inducer recognition and transcriptional activation. Whereas this modification in BenR
abolishes protein activity, in XylS, it increases the response to several inducers, including acetyl salicylic acid, to levels close to
those achieved by the canonical inducer. Moreover, by constructing chimeric proteins with swapped N-terminal domains, we
created novel regulators with mixed promoter and inducer recognition profiles. As a result, a collection of engineered TFs was
generated with an enhanced response to benzoate, 3-methylbenzoate, 2-methylbenzoate, 4-methylbenzoate, salicylic acid,
aspirin, and acetylsalicylic acid molecules for eliciting gene expression in E. coli.
KEYWORDS: transcriptional regulation, protein engineering, homology modeling, gene regulatory network, reverse engineering,
bacterial expression system
Transcriptional regulation plays a central role in theadaptation of cells to changing environmental conditions.
In bacteria, this step is mainly regulated by the interaction of
RNA polymerase (RNAP) with the promoter region through
the use of many sigma factors and by a large number of
transcription factors (TFs) that can promote or block RNAP
binding or further steps in transcription.1 With the growing
interest in the engineering of living cells for novel
biotechnological and biomedical applications, a special focus
has emerged in understanding gene regulation at the molecular
level.1−4 In this context, many different classes of TFs have
been extensively characterized in the molecular detail from
bacteria to mammals, and this knowledge has allowed a
number of engineering projects, where natural systems can be
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repurposed to display novel behaviors.1,5−9 Attempts in this
direction are very diverse, and examples include the
construction of mutated variants of natural TFs with enhanced
or modified performance,10−15 the recombination of protein
domains to create TFs with completely altered specificity or
dynamical behavior,16,17 and the mining of novel regulators
from genomes or metagenomes.18,19 Additionally, the revolu-
tion provided by the CRISPR/Cas9 system has also impacted
the field of gene regulation, as this system has been repurposed
to construct fully synthetic expression systems based on RNA/
DNA interaction.20−22
Despite the progress in the engineering of novel expression
systems, a critical bottleneck relies on the selection of suitable
signal-recognition modules related to the application of
interest. In other words, whereas many different TFs are
well-characterized as responsive to small molecules (sugars,
ions, aromatics, etc.), many times, the application at stake
requires systems responsive to unusual compounds.23 There-
fore, the construction of TF variants with enhanced
responsiveness to non-natural ligands has become more
appealing. Approaches to accomplish this task range from
the use of laborious random mutagenesis followed by
selection11,12 to the use of computational analysis to guide
rational design.24 Here we focused on the engineering of novel
expression systems responsive to commercially available drugs
suitable to in vivo administration to a mammalian animal. Our
Figure 1. Analysis of BenR homologues and target promoters in Pseudomonas. (A) Analysis of protein conservation between XylS from
Pseudomonas putida mt-2 and BenR homologues from strains of P. putida (Ppu_3159, Pput_2555, PputGB1_2689, PputW619_2886, PPS_2765),
P. entomophila (PSEEN3143), P. f luorescens (Pfl01_2968, PFL_3858), and P. aeruginosa (PA14_32080, PLES_27771, PA2518). PbanA in the
second line indicates the promoter from P. putida KT2440 (Ppu_3159). Only the region relative to the HTH domain is shown. Critical aa’s for
DNA recognition (labeled as A-binding and B-binding) are marked with inverted triangles, with conserved regions colored in yellow. In the middle,
the schematic representation of the BenR interaction with the RNAP and the σ factor (necessary for the correct initiation of transcription) and the
target promoter shows the two binding sites (Od and Op) and the −35/−10 boxes at Pb and Pm. (B) Promoter alignment for Pm from P. putida
mt-2 and for Pb from several Pseudomonas strains. The two conserved boxes (A and B) from Od and Op binding sites are highlighted.
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particular interest was focused on acetylsalicylic acid (ASA or
aspirin), a longstanding, safe and widely used drug. This
compound has been applied in synthetic regulatory circuits to
deliver lytic proteins to tumors in vivo, representing a
promising field for the development of tumor-targeting circuits
for clinical applications.25 As a starting point, we sought to
investigate the molecular mechanisms of signal recognition by
two homologous regulators of Pseudomonas putida, namely,
BenR and XylS. These two TFs are members of the AraC/XylS
family of transcriptional activators26−28 that recognize different
aromatic compounds with structural similarities to ASA. Yet,
whereas both regulators share ∼60% amino acid (aa) identity,
BenR is responsive to only benzoate,27 whereas XylS can
recognize a large number of substituted variants.29 Addition-
ally, some crosstalk between these two regulators and their
target promoters has been characterized, as XylS can recognize
only its target promoter Pm, whereas BenR can efficiently
activate its natural target Pb as well as Pm.27
In this study, we have investigated the molecular
mechanisms of signal recognition by these two regulators
using computational tools and in vivo validation. By
constructing a model for the ligand-binding domain of BenR
and performing molecular docking with benzoate and a
collection of analogues, we identified a potential binding
pocket strongly conserved between these two TFs. Thereby,
we used site-directed mutagenesis and the construction of
chimeric proteins to validate the identified binding pocket of
the protein. Finally, we demonstrated how a single aa position
plays a critical and opposite role in the activity of both
proteins. Some changes in this position in BenR resulted in the
complete loss of protein activity, whereas the same in XylS
triggered an enhanced response to benzoate analogues,
including ASA. The results presented here thus provide
insights into not only the mechanism of signal recognition
by members of the AraC/XylS family but also the engineering
of a regulatory device responsive to aspirin.
■ RESULTS
Analysis of Conserved Elements in BenR and XylS
Close Homologues and Target Promoters. To investigate
the molecular mechanisms accounting for the functional
differences between BenR and XylS, we analyzed the close
homologues of these proteins present in the genomes of some
species of Pseudomonas. As represented schematically in Figure
1, these proteins are TFs formed by two domains, the N-
terminal (AraC domain), which is required for ligand
recognition,30 and the C-terminal domain composed of two
helix-turn-helix (HTH) regions required for the recognition of
the distal and proximal operators (Od and Op) upstream of the
target promoters.27,31 It is proposed that two monomers of
XylS are required for the activation of the Pm promoter, each
binding to an operator region and contacting an A and B box
conserved within this region. A previous study32 used alanine
scanning mutagenesis to identify four residues in XylS required
for the recognition of the A boxes (Arg242, Asn246, Glu249,
and Lys250) and five required for the interaction with boxes B
(G295, Arg296, Asp299, Asn300 and Arg302). As can be
observed in the protein alignment between BenR and XylS
homologues, most of these positions are well conserved in the
proteins analyzed, with the exception of residues Asn246,
Lys250, and Asn300 (Figure 1A). It is surprising to notice that
whereas the change of Asn to Ala at position 246 in XylS
reduced the capability of this protein to activate Pm by half,
Ala is found to be well-conserved in most BenR proteins
analyzed. This indicates that BenR homologues might be less
stringent in the interaction at the A box of the target
promoter.27 In the same direction of this hypothesis, the
analysis of Pm and Pb promoters from several Pseudomonas
strains reveals that most features (A and B boxes, −35/10
region) are well conserved, except for the A box of Pb (the
target of the BenR studied here) from Pseudomonas putida
KT2440 (Figure 1B). In this sense, to check the effect of the A
box in the interaction between XylS and Pm and Pb promoters,
we assayed the promoter activity using a lux reporter system.
We used a wild-type xylS gene expressed from a pSEVA
vector33 and Pm, Pb, and Pb-syn1 (a Pb variant with the
recomposed A box of the Od region27). Using this system, we
observed that whereas XylS could recognize Pm very
efficiently, it was not able to induce Pb activity in response
to the inducers tested (Figure 2). However, when a version of
Pb with the reconstituted A box (Pb-syn1) was used, a strong
induction of promoter activity was observed in response to the
inducers used (Figure 2).27 Taken together, these results
reinforce the notion that whereas XylS has a critical
requirement for complete A and B boxes at the Od and Op
regions, BenR is less stringent for promoter recognition.
Figure 2. Recognition of Pm and Pb by XylS. For the analysis, E. coli DH5α strain was transformed with pSEVA438 (harboring a functional XylS
expressed with its native promoter33) and pSEVA226 (a reporter vector with the luxCDABE operon33) harboring Pm, Pb, or Pb-syn1, a variant of
Pb endowed with the A box of Od from Pm.27 All strains were grown on minimal media to the midexponential phase and then exposed for 3 h to
100 μM benzoate (Bz), 3-methylbenzoate (3MBz), 3-chlorobenzoate (3CBz), or 4-methylbenzoate (4MBz). The graphs represent the fold change
of promoter activity relative to the noninduced condition.
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Single Amino Acid Position Is Critical for Aromatic
Recognition in BenR and XylS. After tracing critical
differences in the DNA recognition requirements between
BenR and XylS, we decided to investigate aa differences that
could explain the divergence in the ligand selectivity between
these two TFs. As presented before, BenR has a very narrow
inducer selectivity because this TF can only respond to
benzoate as an inducer under natural conditions. However,
XylS can be activated by a diverse collection of aromatic
inducers, such as benzoate and methylated or chlorinated
benzoate analogues.29 To gain insight into the molecular
mechanisms responsible for these differences, we constructed a
3D protein model for the N-terminal region of BenR using
homology modeling. The resulting model was subjected to
molecular docking using benzoate, 3-methylbenzoate (3MBz),
4-methylbenzoate (4MBz), and salicylate (Sal). Using this
approach, we obtained a protein structural model (Figure 3A)
and identified a potential cavity on the protein surface that
accommodates a benzoate molecule (Figure 3B). Additionally,
our results suggest that the identified binding pocket binds
with less affinity for the benzoate analogues, indicating that the
inducer selectivity could be based on size exclusion. By
analyzing the model and the predicted binding pocket, we
could identify eight aa’s (His 28, Arg 66, Leu 72, His 77, Trp
88, Leu 104, Pro 107, and Val 111) that contributed to the
surface of the cavity (Figure 3B,C). We then compared these
aa’s between BenR and XylS, hypothesizing that a change in
some of these aa’s could explain the difference in ligand
specificity between these two regulators. To our surprise, six
out eight aa’s from the predicted binding pocket were
conserved between the two proteins. The differences were at
positions 28 and 111, representing histidine (28) and valine
(111) in BenR and tyrosine (28) and alanine (111) in XylS.
Because alanine has a shorter side chain, we hypothesized that
this could lead to a bigger binding pocket in XylS that could
better accommodate the methylated or chlorinated benzoate
analogues (Figure 3C and Table S3).
The difference in binding energy suggests that mutation of
Val111 to Ala increases the affinity of 3MBz (Table S3). To
investigate this possibility, we constructed point mutations in
benR and xylS at aa positions 111 and 110, as we noticed that
this last position, while not involved in the binding pocket, was
also not conserved between the two regulators (Figure 4A). In
addition to the point mutations, we constructed a chimaera
between the N-terminal part of XylS and the C-terminal part of
BenR and also subjected this TF to mutagenesis. All assays
were performed using the cognate promoter for each TF (i.e.,
Pb for BenR and Pm for XylS) controlling a green fluorescent
Figure 3. Mapping ligand binding sites in BenR by protein structure prediction and molecular docking. (A) Homology model of wild-type BenR
showing the putative binding site of the ligands. (B) Docking of benzoate (Bz), 3-methylbenzoate (3MBz), 4-methylbenzoate (4MBz), and
salicylate (Sal) at the wild-type BenR protein, highlighting the critical aa participating in the putative binding site. (C) Docking of BenR-V111A
variant showing the putative binding site, as in panel B.
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protein (GFP) reporter gene (Figure 4A) to allow inves-
tigation at the single-cell level34,35 (Figures S3−S5). The
promoter activities were calculated after 5 h of exposure to the
different inducers. As can be observed in Figure 4B, wild-type
BenR was specific to benzoate at all concentrations tested,
whereas wild-type XylS displayed a preferential response to
3MBz, an intermediated response to benzoate, and a lower
response to 2MBz and 4MBz. When we mutated position 110
of BenR from Pro to Ala or Gln (the aa found at this position
in XylS), we could observe that the mutants presented the
same expression profile as the wild type but with reduced
efficacy (Figure 4C). However, when position 111 was
changed from Val to Ala in BenR, the resulting protein variant
did not display any response to the inducers tested. Contrary
to the expected, this change (Val 111 to Ala) did not widen the
inducer specificity of BenR. By the same token, the
construction of BenR mutants with changes at both positions
110 and 111 also resulted in nonfunctional proteins (Figure
S1), potentially due to the role of Val111 in signal recognition.
Therefore, it is worth noticing that the exchange of a shorter
side-chain aa (Ala) for a major side-chain aa (Val) does not
necessarily result in a spatial decrease in the aa binding pocket.
Figure 4. Experimental identification of critical aa’s for inducer recognition in BenR and XylS. (A) Schematic representation of BenR and the
chimeric protein X-BenR (a fusion between the N-terminal domain of XylS with the C-terminal domain of BenR), showing the nonconserved
positions 110 and 111 tested here. All protein variants were tested with a GFPlva reporter under the control of the cognate promoter (i.e., Pb for
BenR and X-BenR and Pm for XylS). (B) Analysis of the promoter activity of BenR-Pb and XylS-Pm in response to different concentrations of
benzoate (Bz), 3-methylbenzoate (3MBz), 2-methylbenzoate (2MBz), 4-methylbenzoate (4MBz), and salicylic acid (Ac Sal). The solid line
indicates the average from three independent experiments, whereas the dashed lines represent the lower and higher limits of the standard deviation.
(C) Analysis of the promoter activity for BenR mutants at positions 110 (BenR-P110A and BenR-P110Q) and 111 (BenR-V111A). (D) Analysis of
the promoter activity for chimeric X-BenR protein and its variant with a mutation in position 111 (X-BenR-A111V) as well as for the mutated
version of XylS (XylS-A111V). The promoter activities (panels B−D) reported here were calculated after 5 h of exposure to the different inducers.
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Taken together, these results indicate that Val111 is key for
inducer recognition by BenR, and it is possible that it is related
to the strengthening of its association with the effector binding
pocket identified by homology modeling and molecular
docking.
The construction of the chimeric protein harboring the N-
terminal of XylS (the region responsible for ligand
recognition) and the C-terminal of BenR (which recognizes
DNA) resulted in the new protein X-BenR that displayed an
induction profile similar to that of XylS for the 3MBz induction
but with a reduced efficacy (Figure 4D). However, X-BenR
increased its inducer response to 3MBz at the same level as
that which BenR responds to Bz (Figure 4D and Figure S2),
perhaps because Pm has a higher promoter activity than Pb. To
check the role of position 111 in the inducer selectivity of XylS,
we constructed point mutations of XylS and X-BenR by
changing the alanine at this position for a valine. Unexpectedly,
the resulting mutant proteins displayed an enhanced response
to the optimal inducer (3MBz) as well as to the suboptimal
inducers benzoate, 2MBz, 4MBz, and salicylic acid (Figure
4D). From these results, it appears that the C-terminal of BenR
does not allow as much promiscuity as that found in XylS.
These results strengthen the notion that the required elements
for inducer selectivity are placed in the first 196 aa’s of these
proteins,36 although the effector response is not completely
independent of, but is also related to, the C-terminal DNA-
binding domain. Finally, attempts to construct a chimeric
protein harboring the N-terminal of BenR and the C-terminal
of XylS (named B-XylS) resulted in nonfunctional products
with no detectable response to benzoate or 3MBz (Figure S2).
Yet the single-cell analysis of promoter induction by flow
cytometry showed that whereas wild-type BenR- and XylS-
based expression systems presented clear unimodal patterns
(i.e., with a single population of fluorescent cells), the X-BenR
chimaera and mutated versions of XylS and X-BenR displayed
a wider population distribution that could indicate stable
subpopulations (Figures S3−S5). Taken together, these results
evidenced a remarkably different role of position 111 between
BenR and XylS, which led to the identification of two TF
variants with an enhanced response to a wide range of
benzoate derivatives.
Transcriptional Factors Responsive to a New Set of
Aromatic Compounds and Aspirin. After the inducer
recognition profiles of BenR and XylS are characterized, we
assay the TF variants for a new set of inductors. Figure 5
represents the overall performances of the TFs in response to a
new set of benzoate derivatives (Figure 5A). As shown in
Figure 5B, BenR (Pb-BenR) and X-BenR (X-BenR/Pb)
produced the lowest promoter outputs and were exclusively
responsive to benzoate (BenR) or 3MBz (X-BenR). Because
these proteins have a BenR C-terminal domain, they can
recognize both Pm and Pb. On the contrary, XylS has an
intermediate level of promoter output and a preference for
3MBz, followed by benzoate, and only a minor response to
2MBz and 4MBz. Yet the mutated version of X-BenR (X-
BenR-A111V/Pb) promoted an overall increased response to
the suboptimal inducers of XylS (XylS/Pm) and also a
response to aspirin and ASA. Finally, the mutated version of
XylS (XylS-A111V) displays a remarkable gain of response to
all benzoate derivatives tested, including aspirin and ASA, with
Figure 5. Analysis of transcriptional response to aromatic compounds and aspirin. (A) Schematic representation of the chemical structure of the
different inducers tested. (B) Promoter activity of the different proteins reported here after 3 h of exposure to the different inducers. (All
compounds were tested at 1 mM.) Aspirin refers to the commercial formulation obtained from a conversional drug store (with concentration
adjusted to 100 μM), whereas acetylsalicylic acid specifies the pure compound obtained from Sigma-Aldrich. (C) Fold change calculated for each
expression system in response to the different inducers used. Error bars represent the standard deviations from three independent experiments.
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promoter outputs similar to those of wild-type XylS induced
with its optimal effector 3MBz (Figure 5B). When fold-change
is calculated relative to noninduced conditions, it can be
noticed that the maximal induction of the XylS-A111V (XylS-
A111V/Pm) system (∼76-fold) exceeds that of the wild-type
XylS (∼69-fold, Figure 5C). In this new system, the response
to ASA reaches 42- and 45-fold, respectively, yet because this
enhanced response could be the result of the construction of a
TF with a promiscuous effector specificity, we tested the
response of XylS-A111V to toluene, xylene, phenol , and a
number of nonaromatic inducers (L-arabinose, fructose,
glucose, isopropyl β-D-1-thiogalactopyranoside (IPTG), and
arsenite; Figure S6A). As can be observed in Figure S6B, the
system did not respond to any of these compounds, whereas
further tests with vanillin, 4-hydroxybenzoic acid, and benzilic
alcohol also show only a minor effect of this last compound on
the activity of X-BenR-A111V and XylS-A111V (Figure S6C).
Taken together, these data show that benzoate analogues are
the preferential inducers of the newly generated systems
described here.
Promoter Engineering Further Enhances X-BenR-
A111V Response to Nonoptimal Inducers. The data
presented above demonstrate how changes in the aa sequence
of BenR and XylS could drastically change the inducer
specificity of these two regulators, yet, in the case of BenR,
previous studies by our group have demonstrated that changes
in the operator sequence of its target promoter (Pb) could also
impact the way this regulator responds to suboptimal inducers.
More specifically, because Pb is formed by one complete
operator sequence (harboring boxes A and B, Figure 1B) plus
another incomplete operator (where the A box is missing), the
addition of the A box to restore the second binding site makes
the BenR/Pb system more responsive to the suboptimal
inducer 3MBz.27 In this sense, because we noticed a gain of
function for the X-BenRA111V chimeric protein constructed
here, we decided to investigate if this regulator would have an
improved response to the new inducers when activating a
mutated version of Pb harboring two functional operators (Pb-
syn1, Figure 6A). As shown in Figure 6B, the newly created X-
BenR-A111V regulators displayed an increased response to
most inducers tested, with a more than two-fold change in
promoter activity when induced with Bz, 3MBz, 2MBz, and
4MBz. These results confirm the previous notion that
promoter architecture is an important element controlling
the inducer response to suboptimal inducers in BenR
regulators and also adds a new modulation level (the promoter
itself) for the optimization of biosensors from the XylS family.
■ DISCUSSION
The results presented here shed some light on the molecular
mechanisms for ligand and promoter recognition of BenR and
XylS from P. putida. Of particular interest, XylS has been
extensively investigated both in the context of the natural
regulation of the meta pathways in P. putida mt-237−39 as well
as for its applicability as a universal expression system for
Gram-negative bacteria.12,40,41 Previous attempts have inves-
tigated the critical aa for inducer recognition and promoter
activation,12,32,42 but these studies have not provided a clear
molecular proposition on how this protein interacts with its
ligands or the promoter. On the contrary, fewer studies have
investigated BenR at the molecular level.26,27,43 As for the
findings presented here, we initially expect that changes in the
aa of the identified binding pocket of BenR could adjust the
ligand selectivity of the protein, as reported for the TtgV
regulator that can discriminate between molecules with one or
two aromatic rings.44,45 Yet, contrary to the initial size
exclusion model proposed, our experimental validation of the
binding site prediction supports a role for position 111 in both
BenR and XylS as a key element connecting the binding of the
ligand to the changes in domain arrangement of the protein,
similarly to the mechanism of activation of AraC of E. coli.46 In
this sense, the modeling of BenR with both N- and C-terminal
domains suggests that residue 111 is close to the interface
between the ligand binding and DNA binding domains
(Figures S7, S8, and S10). In this scenario, valine could
make critical interactions in BenR that are disrupted when this
aa is changed for alanine. In the same way, changing alanine in
XylS (or in X-BenR) for valine would allow the establishment
of novel interactions that could enhance the performance of
the protein, allowing the recognition of novel inducers such as
salicylate or ASA. Previous work aiming at the construction of
a XylS-Pm expression cassette with an increased response to
3MBz has reported several mutations in both the N- and C-
terminal regions of XylS. Among these mutants, an A111V
mutation has been reported before, also based on the 3D
modeling of XylS, suggesting that this A111 residue interacts
Figure 6. Effect of promoter architecture on the sensitivity of the X-
BenR A111V regulator. (A) Schematic representation of the assayed
system, where a wild-type or a synthetic Pb promoter27 harboring a
completed Op binding site has been used to control GFP expression.
(B) Analysis of promoter activity for the X-BenR A111V mutant in
response to benzoate (Bz), 3-methylbenzoate (3MBz), 2-methyl-
benzoate (2MBz), 4-methylbenzoate (4MBz), salicylic acid (Ac Sal),
acetyl salicylic acid (ASA), and aspirin. All inducers were used at 100
μM. Vertical bars are the standard deviations from three independent
experiments.
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with the effector binding pocket. However, in this work,
authors performed the A111V mutation together with one or
two additional aa positions.12 Therefore, the role of position
111 in XylS has never been investigated in isolation. It was
interesting to notice that changing the promoter architecture of
Pb allowed the increased responsivity of the chimeric X-BenR-
A111V to benzoate analogues, yet this strategy was not able to
improve the responsivity to ASA or aspirin. This could indicate
that the responsivity to these two compounds would require
some additional interactions with the TF that are possible only
in XylS, and this should be further investigated in the future.
Additionally, most of the previously reported mutations
affecting the XylS inducer response specificity are located
close to the predicted binding pocket identified in this work
(Figure S9), increasing the confidence of the computational
approach used here.
It is interesting to notice that the mutations affecting the
signal specificity of BenR and XylS either completely abolish
the protein activity or generate regulators with an enhanced
response to a series of ligands. In other words, it was not
possible to switch the specificity of the ligand-binding domains
from one compound to another. This notion resembles the
stem protein model investigated for XylR (another aromatic
responsive regulator from P. putida mt-2), where the selection
of mutant proteins responsive to new ligands resulted in
variants promiscuous to several aromatic compounds.47 It is
also important to notice that the computational approach used
here predicted the ligand binding pocket site together with the
conservation analysis of phylogenetically related protein
homologues, which represents a powerful tool to guide the
rational design of TF variants. Similar approaches could be
applied to other members of the AraC/XylS family of TFs as
well as to regulators from different families, aiming at the
generation of novel expression systems for inducers of interest.
Additionally, recent approaches based on the construction and
high-throughput characterization of chimeric proteins have
been used to create new benzoate responsive regulators. Yet
this approach has generated very modest induction levels for
the final engineered proteins (with approximately three-fold
changes), whereas the approach used here yielded an induction
of about 40 times for the mutated version of XylS.48 Whereas
NahR, a LysR-type transcriptional regulator, is able to induce
gene expression in response to salicylate,10 the TFs engineered
here represent a new set of tools for the expression of genes of
interest in response to salicylate and ASA. Additionally, the
expression system based on XylS-A111V displays a ∼10-fold
change in response to 10 μM of ASA, which is in the same
range of the observed sensitivity for the natural ASA-
responsive regulator NahR (which reaches a 20-fold change
in response to a similar concentration of the compound10).
These concentrations are in the range of the physiological
concentrations of ASA in blood, as this molecules can reach
levels as high as ∼30 μM after 20 min of administration of the
drug.49 Yet, whereas the new aspirin-responsive regulator
presented here is not specific to this compound, it is reasonable
to think that during real applications (i.e., in vivo in a
mammalian cell model), systems would not be exposed to
benzoate or any of its analogues. Therefore, the lack of
exclusive responsivity to aspirin would not be an issue under
real case applications. Taken together, these results demon-
strate the expansion of the genetic toolbox for the engineering
of synthetic circuits inducible to safe drugs.
■ MATERIALS AND METHODS
Bacterial Strains and Growth Conditions. The plasmids
and bacterial strains used in this study are listed in Table 1.
Cloning and assay procedures were performed in E. coli DH5α.
All DNA manipulations, including cloning, polymerase chain
reaction (PCR), and transformations of E. coli, were performed
according Sambrook et al.50 Bacterial strains were routinely
grown in LB media supplemented with 36 μg mL−1
chloramphenicol or, when necessary, in M9 minimal media
(6.4 g L−1 Na2HPO4·7H2O, 1.5 g L
−1 KH2PO4, 0.25 g L
−1
NaCl, 0.5 g L−1 NH4Cl, 2 mM MgSO4, 0.1 mM casamino
acids, 1% glycerol) supplemented with chloramphenicol at 36
μg mL−1. Liquid cultures were shaken at 180 rpm at 37 °C for
Table 1. Strains and Plasmids Used in This Work
strains and plasmids description reference
Strains
P. putida KT2440 P. putida mt-2 derivative 59
E. coli DH5α F- φ80 ΔlacZ ΔM15 Δ(lacZYAA-argF) U169 recA1 endA1 hsdR17 R-M+ supE4 thi gyrA relA 50
Plasmids
pSEVA438 Sm/SpR, ori pBBR1; Expression vector harboring the xylS-Pm expression system 33
pSEVA226 KmR, ori RK2; reporter vector harboring the luxCDABE operon 33
pSEVA226-Pb KmR, ori RK2; pSEVA226 with the Pb promoter cloned as a EcoRI/BamHI fragment 27
pSEVA226-Pm KmR, ori RK2; pSEVA226 with the Pm promoter cloned as a EcoRI/BamHI fragment 27
pSEVA226-Pbsyn1 KmR, ori RK2; pSEVA226 with the Pbsyn1 promoter cloned as a EcoRI/BamHI fragment 27
pMR1 CmR, ori p15a; dual mCherry/GFPlva promoter probe vector 51
pMR1-BenR-Pb CmR, ori p15a; pMR1 variant with benR-Pb expression system closed as a BglII/EcoRI fragment this study
pMR1-BenR-V111A CmR, ori p15a; pMR1-BenR-Pb with benR gene mutated at position V111A this study
pMR1-BenR-P110A CmR, ori p15a; pMR1-BenR-Pb with benR gene mutated at position P110A this study
pMR1-BenR-P110Q CmR, ori p15a; pMR1-BenR-Pb with benR gene mutated at position P110Q this study
pMR1-BenR-A110A111 CmR, ori p15a; pMR1-BenR-Pb with benR gene mutated at positions P110A and V111A this study
pMR1-BenR-Q110A111 CmR, ori p15a; pMR1-BenR-Pb with benR gene mutated at positions P110Q and V111A this study
pMR1-X-BenR CmR, ori p15a; pMR1-BenR-Pb with benR with the N-terminal region replaced by that of xylS this study
pMR1- X-BenR-A111V CmR, ori p15a; pMR1-X-BenR with chimeric X-benR gene mutated at position A111V this study
pMR1-XylS-Pm CmR, ori p15a; pMR1 variant with xylS-Pm expression system closed as a BglII/EcoRI fragment this study
pMR1-XylS-Pm-A111V CmR, ori p15a; pMR1-XylS-Pm with xylS gene mutated at position A111V this study
pMR1-B-XylS CmR, ori p15a; pMR1-XylS-Pm with xylS with the N-terminal region replaced by that of benR this study
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∼16 h. The aromatic compounds used as inducers were all
purchased from Sigma-Aldrich. The inducers and their
catalogue numbers are benzoic acid (242381), 3-methylben-
zoic acid (3117714), 2-methylbenzoic acid (169978), 4-
methylbenzoic acid (117390), salicylic acid (S5922), ASA
(A5376), Bayer aspirin (1000 μM) and isopropyl β-D-1-
tiogalactopiranosida (IPTG) (I5502), sodium arsenite
(S7400), toluene (244511), xylene (214736), phenol
(P1037), L-arabinose (A3256), D-(−)-fructose (F0127), and
D-(+)-glucose (G8270).
Plasmid Construction. The benR gene and PbenR and Pb
promoters were amplified by PCR using specific primers
(Table S1) and P. putida KT2440 genomic DNA as the
template. The PCR products were digested with specific
restriction enzymes (see the underlined sequences in Table
S1) and cloned into the pMR1 vector,51 yielding the pMR1-
BenR-Pb (BenR) construct. BenR mutants, pMR1-BenR-
P110A (BenR-P110A), pMR1-BenR-P110Q (BenR-P110Q),
pMR1-BenR-V111A (BenR-V111A), pMR1-BenR-A110A111
(BenR-A110A111), and pMR1-BenR-Q110A111 (BenR-
Q110A111), were generated by circular polymerase extension
cloning (CPEC) site-directed mutagenesis methodology52
using the pMR1-BenR-Pb construct as the template and the
primers listed in Table S1. (Mutated base pairs are highlighted
in bold and underlined.) The xylS gene and Ps and Pm
promoters were amplified by PCR using pSEVA438 vector as
the template,33 yielding the pMR1-XylS-Pm (XylS) construct.
XylS mutant pMR1-XylS-A111V (XylS-A111V) was con-
structed by CPEC site-directed mutagenesis using the
pMR1-XylS-Pm construct as the template and the primers
listed in Table S1. (Mutated base pairs are highlighted in bold
and underlined.) Two chimeric transcription factors were
constructed. The first construct was generated by directly
linking the N-terminal domain of XylS and the C-terminal
domain of BenR using, respectively, P. putida mt-2 and
KT2440 strains as templates. The second construct was
generated by linking the N-terminal domain of BenR and the
C-terminal domain of XylS using the pMR1-BenR-Pb and the
pMR1-XylS-Pm as templates. All fragments were amplified by
PCR. In the first construct, the PbenR promoter was cloned
upstream the chimaera, and the Pb promoter was cloned
upstream the GFPlva reporter gene, yielding the pMR1-X-
BenR (X-BenR). The chimaera mutant pMR1-X-BenR-A111V
(X-BenR-A111V) was constructed using the vector pMR1-X-
BenR as the template. In the second construct, the Ps and Pm
promoters were cloned upstream the chimaera and the GFPlva
reporter gene, respectively, generating the pMR1-B-XylS (B-
XylS). All PCR amplifications were performed using Phusion
high-fidelity DNA polymerase (Thermo Fisher Scientific). All
resulting constructs were sequenced using dideosyterminal
methods to confirm the correct assembly prior to the
fluorescence assays. The aa sequences of the final construct
generated here are represented in Table S2.
GFP Fluorescence Assay and Data Processing. To
measure the activity of all constructions performed in this
work, plasmids were transformed into E. coli DH5α. Freshly
plated single colonies were grown in M9 minimal media
supplemented with suitable antibiotics. The cultures (10 μL)
were then assayed in a 96-well microplates with 170 μL of M9
minimal media and 20 μL of the different compounds tested.
When required, benzoic acid (Bz), 3-methylbenzoic acid
(3MBz), 2-methylbenzoic acid (2MBz), 4-methylbenzoic acid
(4MBz), salicylic acid (0−1000 μM), ASA, Bayer aspirin
(1000 μM) and IPTG, sodium arsenite, toluene, xylene,
phenol, L-arabinose, fructose, and glucose (100 μM) were
used. Cell growth and GFP fluorescence were quantified using
a Victor X3 plate reader (PerkinElmer). The responsiveness of
regulators was calculated as arbitrary units using the ratio
between fluorescence levels and the optical density at 600 nm
(reported as GFP/OD600) or the luminescence by optical
density at 600 nm after background correction. As a control, all
assays were performed without the addition of compounds
(inducers) as the threshold background signal during
calculations. Fluorescence and absorbance measurements
were taken at 30 min intervals up to 8 h at 37 °C. All
experiments were performed in technical and biological
triplicates. Raw data were processed using ad hoc R script
(https://www.r-project.org/).
Flow Cytometry Analysis. High-throughput single-cell
analysis of the bacteria carrying the BenR, XylS, XBenR, XylS
mutant, or XBenR mutant systems was run as follows. First, we
selected single colonies of the transformed strain (E. coli
DH5α) and cultivated it overnight in M9 minimal medium
(containing 6.4 g/L Na2HPO4·7H2O, 1.5 g/L KH2PO4, 0.25
g/L NaCl, and 0.5 g/L NH4Cl) supplemented with 2 mM
MgSO4, 0.1 mM CaCl2, 0.1 mM casamino acids, chloram-
phenicol (36 μg/mL), and 1% glycerol as the sole carbon
source (supplemented M9) at 37 °C and 180 rpm. Next,
overnight grown cells were diluted to 1:10 in fresh
supplemented M9 and were grown for 3 h at 37 °C and 180
rpm. At this point, the cultures were induced with different
concentrations (0, 10, 100, 250, 500, and 1000 μM) of the
inducers. The BenR system was induced with benzoate, XylS
was induced with benzoate and 3-metilbenzoate, X-BenR was
induced with 3-metilbenzoate, and XylS mutant and X-BenR
mutant were induced with benzoate, 3-metil-benzoate, salicylic
acid, and acetyl-salicylic acid. After 3 h of induction, the
cultures were stored in ice and immediately analyzed for GFP
fluorescence using the Millipore Guava EasyCyte mini flow
cytometer (Millipore). The results were analyzed by R scripts
using the flowCore and flowViz packages available on
Bioconductor (https://bioconductor.org/).
3D Structure Model Construction and Docking
Analysis. The 3D models presented here were generated by
SWISS-MODEL server (https://swissmodel.expasy.org/)
using the best homologue for each protein. For the
visualization of the models, PyMol (https://pymol.org/) and
Chimaera (https://www.cgl.ucsf.edu/chimera/) were used. To
predict the potential binding site for the aromatic ligands,
Swiss-Docking (https://www.swissdock.ch/) and Docking
Server (https://www.dockingserver.com/web) were used.
Additionally, Jalview (http://www.jalview.org/) was used for
the visualization of protein and DNA alignments generated by
T-coffee (http://tcoffee.crg.cat/apps/tcoffee/all.html). From
the generated 3D models using SwissModel,53 models were
first inspected visually for histidine protonation and Asn and
Gln positioning. Models were further refined by minimizing
their structure with the AMBER FF14SB54 force field using
AMBER.55
Molecular Docking. The energy maps were computed
inside the grid, with a grid size of 26 × 30 × 40. Dockings were
carried out using the LGA/LS algorithm implemented on
Autodock 456 (version 4.2.6, with a maximum of 27 000
generations or 2 500 000 energy evaluations). Fifty independ-
ent runs were performed, and the resulting poses were
clustered according to the ligand heavy-atom rmsd using a
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cutoff of 2 Å, thus defining a result. 3D structures of the ligands
were generated using OpenBabel57 and manually inspected.
Images were created with VMD.58
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